Merck today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing seven additional Merck patent application claims covering CRISPR gene… DARMSTADT, GERMANY Patent offices in Europe, Israel, South Korea and U.K. issue seven additional grants for Merck’s CRISPR genome-editing technology Merck has 20 allowed CRISPR patents to […]
Transformative Development in Diagnostic Testing, Drug Development and Academic Research Marketplace Provides a Simple, Cost Effective and Scalable Process — — New Probe Technology Advances Company’s Ability to Offer Lower-Cost High-Performance Products and Services in the Clinical Diagnostics Market NEW YORK, NY — Enzo Biochem, Inc. (NYSE: ENZ), an integrated diagnostics and therapeutics company, […]
EChrom and Pannatek Admit to using Agilent Technology Without Permission, Agree to Pay Damages and Cease Using Agilent Technology SANTA CLARA, Calif.–Agilent Technologies, Inc. (NYSE: A) today announced that the company has reached agreement with China-based companies EChrom and Pannatek, as well as certain former Agilent employees, regarding an intellectual property dispute related to Agilent […]
DARMSTADT, GERMANY New framework simplifies and accelerates access to CRISPR intellectual property for research Merck, a leading science and technology company, and the Broad Institute of MIT and Harvard (Boston, Massachusetts) today announced an agreement to offer non-exclusive licenses to CRISPR intellectual property (IP) under their respective control for use in commercial research and product […]
Newomics announces today the issuance of US patent 10,338,079, entitled, “Methods and Systems for Diagnosing Diseases.” The patent is part of the company’s expanding intellectual property portfolio for microfluidics and diagnostics.
SHENZHEN, China and SAN JOSE, Calif. — MGI, a subsidiary of BGI Group, expressed confidence in its core patent portfolio in the field of gene sequencing and vowed to fully support the industry to achieve higher quality, more cost-effective sequencing. With leading products and services, MGI has gained support from users in all countries where it has launched, and […]
SAN DIEGO–Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed three additional patent infringement suits relating to BGI’s sequencing products, including the BGISeq-500, MGISeq-2000, and related chemistry reagents. The first complaint was filed against Complete Genomics, Inc. and other BGI entities in the United States District Court for the Northern District of California alleging infringement of U.S. Patent Nos. […]
BEDFORD, Mass. — Cytonome/ST, LLC, a manufacturer of high throughput flow cytometry / sorting equipment, has filed a lawsuit in the United States District Court for the District of Delaware against NanoCellect Biomedical, Inc., a manufacturer of microfluidic solutions for bulk or single cell sorting. The lawsuit alleges unauthorized use of Cytonome/ST’s patent technology, which is prohibited by law, and is […]
Illumina’s proposed takeover of PacBio raises competition concerns in the supply of specialist DNA sequencing systems in the UK, a CMA investigation has found. The Competition and Markets Authority (CMA) has been investigating the proposed $1.2 billion merger of Illumina, Inc. (Illumina) and Pacific Biosciences of California, Inc (PacBio). The companies are both global suppliers […]
WILMINGTON, Delaware, USA — DeNovix Inc. announces the award of US Patent 10,302,568 for their innovation in the field of cell counting. The CellDrop Automated Cell Counter, engineered with DirectPipette™ Technology, is the first image-based cell counter that completely eliminates the need for slides. The CellDrop Series features permanent sample surfaces that form a reusable […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
